BABA vs SORA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.
SORA exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 3/9 and a catastrophic YoY revenue decline of 44.60%. While the company maintains a strong liquidity position with a current ratio of 5.85, its core operations are failing, evidenced by negative operating margins (-11.91%) and a gross margin (7.46%) that is fundamentally inconsistent with the Luxury Goods industry. The stock has collapsed from a 52-week high of $14.15 to $2.25, and despite a recent short-term bounce, the underlying fundamentals remain precarious.
Compare Another Pair
Related Comparisons
BABA vs SORA: Head-to-Head Comparison
This page compares Alibaba Group Holding Limited (BABA) and AsiaStrategy (SORA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.